Covetrus

Covetrus Liabilities

Delisted

The The Liabilities of Covetrus (CVET) as of Nov 14, 2026 is 1.90 B USD. In the previous year, The Liabilities was 1.96 B USD — a change of -3.06% (lower).

Liabilities

1.90 BUSD

YoY

-3.06%

Last updated:

In 2021, Covetrus's total liabilities amounted to 1.90 B USD, a -3.06% difference from the 1.96 B USD total liabilities in the previous year.

The Covetrus Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2016
866.23 M USD
Jan 1, 2017
955.03 M USD
Jan 1, 2018
739.47 M USD
Jan 1, 2019
2.11 B USD
Jan 1, 2020
1.96 B USD
Jan 1, 2021
1.90 B USD
The Covetrus Liabilities history
YEARLiabilitiesYoY
1.90 BUSD-3.06%
1.96 BUSD-6.94%
2.11 BUSD+184.66%
739.47 MUSD-22.57%
955.03 MUSD+10.25%
866.23 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Covetrus Stock analysis

What does Covetrus do? Covetrus Inc is a global company specializing in providing services and products for veterinarians, animal clinics, and pet owners. It was formed in 2019 through a merger between the animal health divisions of Henry Schein and Vets First Choice. Covetrus traces its history back to 1856 when Henry Schein was founded as a small wholesale drug company. Over the years, the company expanded into new industries and markets. In the 2000s, Henry Schein began serving the animal health industry and established Vets First Choice in 2010 to offer a wider range of services and products to veterinarians and animal clinics. With the merger of Vets First Choice and Henry Schein's animal health division in 2019, Covetrus was created as a company with a broad spectrum of products and services for the animal health industry. Covetrus is headquartered in Portland, Maine, USA, and operates in over 25 countries. Its business model is based on providing services and products for veterinarians, animal clinics, and pet owners. The company is divided into several business segments, including diagnostics, pharmaceuticals, and consumables. In the diagnostics area, Covetrus offers a wide range of laboratory diagnostic services for veterinarians, including blood tests, imaging, fecal tests, and genetic tests. These test results help veterinarians diagnose and treat diseases in pets. In the pharmaceutical area, Covetrus offers veterinary medicines for various types of pets, including dogs, cats, and horses. These medicines are developed by leading pharmaceutical companies, and Covetrus provides veterinarians with a reliable supply chain for these products. The most recent business segment of Covetrus is the consumables area. Here, the company offers a wide range of products for veterinarians and animal clinics, including medical devices, surgical instruments, consumables for routine examinations, and more. In addition to these three main business segments, Covetrus also offers a variety of services, including practice management systems, training for veterinarians and animal clinics, financial services, and more. These services are designed to help veterinarians and animal clinics optimize their operations and improve their quality. The company has also developed a mobile application called 'Covetrus Connect' which provides veterinarians and animal clinics with an easier way to access products and services, place orders, and manage their operations. Overall, Covetrus is an innovative and rapidly growing company in the animal health industry. With a wide range of products and services tailored to the needs of veterinarians, animal clinics, and pet owners, the company is well-positioned to continue growing in this emerging market. Covetrus is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Covetrus's Liabilities

Covetrus's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Covetrus's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Covetrus's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Covetrus's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Covetrus’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Covetrus stock

The Liabilities of Covetrus is 1.90 B USD in 2021.

The Liabilities of Covetrus changed from 1.96 B USD to 1.90 B USD, representing a -3.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Covetrus since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Covetrus historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Covetrus

All Key Metrics — Covetrus